收藏切换
Considerations on investigation on quality standard of Chinese patent medicine
收藏切换
PDF
Li-xing NIE, Yan-pei WU, Jing LIU, Xiao-ru HU, Feng-yan HE, Ya-dan WANG, Qi WANG, Jian-dong YU, Zhong DAI, Feng WEI*, Shuang-cheng MA*
Acta Pharmaceutica Sinica | 2023, 58(8) : 2260 - 2270
Less
收藏切换
Acta Pharmaceutica Sinica | 2023, 58(8): 2260-2270
Considerations on investigation on quality standard of Chinese patent medicine
Full
Li-xing NIE, Yan-pei WU, Jing LIU, Xiao-ru HU, Feng-yan HE, Ya-dan WANG, Qi WANG, Jian-dong YU, Zhong DAI, Feng WEI*, Shuang-cheng MA*
Affiliations
  • National Institutes for Food and Drug Control, Beijing 100050, China
Published: 2023-08-12 doi: 10.16438/j.0513-4870.2023-0337
Outline
收藏切换

Chinese patent medicine (CPM) is an important part of traditional and Chinese medicine (TCM). Its quality has direct impact on the safety and effectiveness of clinical use. The quality standard is the pivotal approach to guarantee the quality of CPM. Due to the complex material basis, multitudinous quality influencing factors and unveiled active ingredients, dose-effect relationship and action mechanism, the investigation on quality standard faces many difficulties. This paper surveys the current quality status of CPM and the general situation of CPM standards. At present, the dosing problem has the crucial impact on the quality of CPM. The current quality standard system of CPM is confirmed and the limitations are indicated. Based on the above analysis, the principles and considerations on investigation of quality standard are proposed as follows: ① Adhere to safety as the bottom line, strengthen the risk-control ability of the standard of CPM; ② Adhere to theory of TCM and comprehensive quality, improve the integrative control level of the CPM standard; ③ Emphasize technological development and innovation, promote the quality control competence of CPM standard; ④ Facilitate planning and coordination, optimize the management of the CPM standard system; ⑤ Reinforce investigation on evaluation method, develop grade evaluation standard, accelerate high-quality development of CPM. Finally, the future perspective on investigation of CPM quality standard is prospected.

Chinese patent medicine  /  investigation on quality standard  /  principle  /  consideration  /  current quality status  /  general situation of standard
Li-xing NIE, Yan-pei WU, Jing LIU, Xiao-ru HU, Feng-yan HE, Ya-dan WANG, Qi WANG, Jian-dong YU, Zhong DAI, Feng WEI, Shuang-cheng MA. Considerations on investigation on quality standard of Chinese patent medicine[J]. Acta Pharmaceutica Sinica, 2023 , 58 (8) : 2260 -2270 . DOI: 10.16438/j.0513-4870.2023-0337
Year 2023 volume 58 Issue 8
PDF
258
103
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2023-0337
  • Receive Date:2023-03-21
  • Online Date:2025-11-21
  • Published:2023-08-12
Article Data
Affiliations
History
  • Received:2023-03-21
  • Revised:2023-04-21
Funding
Affiliations
    National Institutes for Food and Drug Control, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2023-0337
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT